Abbott India Limited (BSE: 500488)
Health Care · Pharmaceuticals · IN
Rs26,245.55
-3.07% today · -16.8% 1Y
Abbott India Limited (BSE: 500488) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.83B.
Over the last twelve months the share price has lost 16.8%, trading between 25.16K and 32.78K.
Tweenvest scores Abbott India Limited across four factors: quality 90/100, value 77/100, growth 70/100, dividend 80/100. Its strongest factor is quality.
500488 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.83B
- Revenue (TTM)
- $740.80M
- P/E
- 34.54
- EPS
- 759.88
- Dividend yield
- 2.00%
- Beta (5Y)
- 0.06
- 52-week high
- Rs32,784.95
- 52-week low
- Rs25,164.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.25M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.00 | -0.07% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.00 | -0.75% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.75 | +0.06% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.30 | +0.24% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.66 | +0.46% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.